Radiation and circulatory disease

Mutation Research - Reviews in Mutation Research

Volumn 770, Issue , 2016, Pages 299-318

  Little, Mark P ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Circulatory disease; Heart disease; Radiation; Review; Stroke

Indexed keywords

ARTICLE; ATOMIC BOMB SURVIVOR; CANCER RADIOTHERAPY; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; HEART DISEASE; HUMAN; ISCHEMIC HEART DISEASE; META ANALYSIS; NEOPLASM; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION EXPOSURE; RADIATION HAZARD; RADIATION SICKNESS; RADIODIAGNOSIS; RISK FACTOR; SYSTEMATIC REVIEW; CARDIOVASCULAR DISEASES; CIRCULATION; IONIZING RADIATION; PATHOPHYSIOLOGY; RADIATION RESPONSE;

BLOOD CIRCULATION; CARDIOVASCULAR DISEASES; ENVIRONMENTAL EXPOSURE; HUMANS; OCCUPATIONAL EXPOSURE; RADIATION DOSAGE; RADIATION, IONIZING;

EID: 84988429901     PISSN: 13835742     EISSN: 13882139     Source Type: Journal    
DOI: 10.1016/j.mrrev.2016.07.008     Document Type: Article

References (110)

1. [1] World Health Organization (WHO), World Health Organization Statistical Information System (WHOSIS). 2015 (updated 17.11.15) http://www.who.int/gho/en/.
2. [2] Centers for Disease Control and Prevention (CDC), CDC Wonder. 2016, Centers for Disease Control and Prevention Underlying Cause of Death 1999–2014 on CDC WONDER Online Database.
3. [3] McMillan, T.J., Bennett, M.R., Bridges, B.A., Darby, S.C., Hendry, J., Jones, B., Kanthou, C., Little, M.P., Taylor, A., Tzoulaki, I., Bouffler, S.D., Zhang, W., Walker, H., Keep, P., Circulatory disease risk. Report of the Independent Advisory Group on Ionising Radiation, 2010, Health Protection Agency, Holborn Gate, 330 High Holborn, London, 1–116.
4. [4] Kreuzer, M., Auvinen, A., Cardis, E., Hall, J., Jourdain, J.R., Laurier, D., Little, M.P., Peters, A., Raj, K., Russell, N.S., Tapio, S., Zhang, W., Gomolka, M., Low-dose ionising radiation and cardiovascular diseases-Strategies for molecular epidemiological studies in Europe. Mutat. Res. Rev. Mutat. Res. 764 (2015), 90–100.
5. [5] Wilson, P.W.F., D'Agostino, R.B., Levy, D., Belanger, A.M., Silbershatz, H., Kannel, W.B., Prediction of coronary heart disease using risk factor categories. Circulation 97 (1998), 1837–1847.
6. [6] Clifton, V.L., Stark, M.J., Osei-Kumah, A., Hodyl, N.A., Review: the feto-placental unit, pregnancy pathology and impact on long term maternal health. Placenta 33:Suppl (2012), S37–S41.
7. [7] Dior, U.P., Hochner, H., Friedlander, Y., Calderon-Margalit, R., Jaffe, D., Burger, A., Avgil, M., Manor, O., Elchalal, U., Association between number of children and mortality of mothers: results of a 37-year follow-up study. Ann. Epidemiol. 23 (2013), 13–18.
8. [8] Slack, J., Risks of ischaemic heart-disease in familial hyperlipoproteinaemic states. Lancet 2 (1969), 1380–1382.
9. [9] Rissanen, A.M., Nikkila, E.A., Aggregation of coronary risk factors in families of men with fatal and non-fatal coronary heart disease. Br. Heart J. 42 (1979), 373–380.
10. [10] Rissanen, A.M., Familial aggregation of coronary heart disease in a high incidence area (North Karelia, Finland). Br. Heart J. 42 (1979), 294–303.
11. [11] Rissanen, A.M., Familial occurrence of coronary heart disease: effect of age at diagnosis. Am. J. Cardiol. 44 (1979), 60–66.
12. [12] Ioannidis, J.P., Prediction of cardiovascular disease outcomes and established cardiovascular risk factors by genome-wide association markers. Circ. Cardiovasc. Genet. 2 (2009), 7–15.
13. [13] Cambien, F., Tiret, L., Genetics of cardiovascular diseases: from single mutations to the whole genome. Circulation 116 (2007), 1714–1724.
14. [14] Adams, M.J., Hardenbergh, P.H., Constine, L.S., Lipshultz, S.E., Radiation-associated cardiovascular disease. Crit. Rev. Oncol. Hematol. 45 (2003), 55–75.
15. [15] Hancock, S.L., Tucker, M.A., Hoppe, R.T., Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. JAMA 270 (1993), 1949–1955.
16. [16] Taylor, C.W., Nisbet, A., McGale, P., Darby, S.C., Cardiac exposures in breast cancer radiotherapy: 1950–1990s. Int. J. Radiat. Oncol.Biol. Phys. 69 (2007), 1484–1495.
17. [17] Little, M.P., Kleinerman, R.A., Stovall, M., Smith, S.A., Mabuchi, K., Analysis of dose response for circulatory disease after radiotherapy for benign disease. Int. J. Radiat. Oncol. Biol. Phys. 84 (2012), 1101–1109.
18. [18] Darby, S., McGale, P., Peto, R., Granath, F., Hall, P., Ekbom, A., Mortality from cardiovascular disease more than 10 years after radiotherapy for breast cancer: nationwide cohort study of 90 000 Swedish women. BMJ 326 (2003), 256–257.
19. [19] Darby, S.C., McGale, P., Taylor, C.W., Peto, R., Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol. 6 (2005), 557–565.
20. [20] Clarke, M., Collins, R., Darby, S., Davies, C., Elphinstone, P., Evans, V., Godwin, J., Gray, R., Hicks, C., James, S., MacKinnon, E., McGale, P., McHugh, T., Peto, R., Taylor, C., Wang, Y., Early Breast Cancer Trialists’ Collaborative Group, effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366 (2005), 2087–2106.
21. [21] Swerdlow, A.J., Higgins, C.D., Smith, P., Cunningham, D., Hancock, B.W., Horwich, A., Hoskin, P.J., Lister, A., Radford, J.A., Rohatiner, A.Z., Linch, D.C., Myocardial infarction mortality risk after treatment for Hodgkin disease: a collaborative British cohort study. J. Natl. Cancer Inst. 99 (2007), 206–214.
22. [22] Hancock, S.L., Donaldson, S.S., Hoppe, R.T., Cardiac disease following treatment of Hodgkin's disease in children and adolescents. J. Clin. Oncol. 11 (1993), 1208–1215.
23. [23] Yamada, M., Wong, F.L., Fujiwara, S., Akahoshi, M., Suzuki, G., Noncancer disease incidence in atomic bomb survivors, 1958–1998. Radiat. Res. 161 (2004), 622–632.
24. [24] Shimizu, Y., Kodama, K., Nishi, N., Kasagi, F., Suyama, A., Soda, M., Grant, E.J., Sugiyama, H., Sakata, R., Moriwaki, H., Hayashi, M., Konda, M., Shore, R.E., Radiation exposure and circulatory disease risk: Hiroshima and Nagasaki atomic bomb survivor data 1950–2003. BMJ, 340, 2010, b5349.
25. [25] Little, M.P., Azizova, T.V., Bazyka, D., Bouffler, S.D., Cardis, E., Chekin, S., Chumak, V.V., Cucinotta, F.A., de Vathaire, F., Hall, P., Harrison, J.D., Hildebrandt, G., Ivanov, V., Kashcheev, V.V., Klymenko, S.V., Kreuzer, M., Laurent, O., Ozasa, K., Schneider, T., Tapio, S., Taylor, A.M., Tzoulaki, I., Vandoolaeghe, W.L., Wakeford, R., Zablotska, L.B., Zhang, W., Lipshultz, S.E., Systematic review and meta-analysis of circulatory disease from exposure to low-level ionizing radiation and estimates of potential population mortality risks. Environ. Health Perspect. 120 (2012), 1503–1511.
26. [26] Schöllnberger, H., Kaiser, J.C., Jacob, P., Walsh, L., Dose-responses from multi-model inference for the non-cancer disease mortality of atomic bomb survivors. Radiat. Environ. Biophys. 51 (2012), 165–178.
27. [27] Little, M.P., Azizova, T.V., Bazyka, D., Bouffler, S.D., Cardis, E., Chekin, S., Chumak, V.V., Cucinotta, F.A., de Vathaire, F., Hall, P., Harrison, J.D., Hildebrandt, G., Ivanov, V., Kashcheev, V.V., Klymenko, S.V., Laurent, O., Ozasa, K., Tapio, S., Taylor, A.M., Tzoulaki, I., Vandoolaeghe, W.L., Wakeford, R., Zablotska, L., Zhang, W., Lipshultz, S.E., Comment on Dose-responses from multi-model inference for the non-cancer disease mortality of atomic bomb survivors (Radiat. Environ. Biophys. (2012) 51:165–178) by Schöllnberger et al. Radiat. Environ. Biophys. 52 (2013), 157–159.
28. [28] International Commission on Radiological Protection, ICRP statement on tissue reactions and early and late effects of radiation in normal tissues and organs – threshold doses for tissue reactions in a radiation protection context, ICRP publication 118. Ann. ICRP 41:1–2 (2012), 1–322.
29. [29] Little, M.P., Tawn, E.J., Tzoulaki, I., Wakeford, R., Hildebrandt, G., Paris, F., Tapio, S., Elliott, P., A systematic review of epidemiological associations between low and moderate doses of ionizing radiation and late cardiovascular effects, and their possible mechanisms. Radiat. Res. 169 (2008), 99–109.
30. [30] Little, M.P., A review of non-cancer effects, especially circulatory and ocular diseases. Radiat. Environ. Biophys. 52 (2013), 435–449.
31. [31] Little, M.P., Lipshultz, S.E., Low dose radiation and circulatory diseases: a brief narrative review. Cardio-Oncology 1 (2015), 1–10.
32. [32] Azizova, T.V., Grigoryeva, E.S., Haylock, R.G.E., Pikulina, M.V., Moseeva, M.B., Ischaemic heart disease incidence and mortality in an extended cohort of Mayak workers first employed in 1948–1982. Br. J. Radiol., 88, 2015, 20150169.
33. [33] Moseeva, M.B., Azizova, T.V., Grigoryeva, E.S., Haylock, R., Risks of circulatory diseases among Mayak PA workers with radiation doses estimated using the improved Mayak Worker Dosimetry System 2008. Radiat. Environ. Biophys. 53 (2014), 469–477.
34. [34] Cutter, D.J., Schaapveld, M., Darby, S.C., Hauptmann, M., van Nimwegen, F.A., Krol, A.D., Janus, C.P., van Leeuwen, F.E., Aleman, B.M., Risk of valvular heart disease after treatment for Hodgkin lymphoma. J. Natl. Cancer Inst., 107, 2015 djv008.
35. [35] Mulrooney, D.A., Yeazel, M.W., Kawashima, T., Mertens, A.C., Mitby, P., Stovall, M., Donaldson, S.S., Green, D.M., Sklar, C.A., Robison, L.L., Leisenring, W.M., Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort. BMJ, 339, 2009, b4606.
36. [36] Viechtbauer, W., Bias and efficiency of meta-analytic variance estimators in the random-effects model. J. Educ. Behav. Stat. 30 (2005), 261–293.
37. [37] DerSimonian, R., Laird, N., Meta-analysis in clinical trials. Control Clin. Trials 7 (1986), 177–188.
38. [38] Higgins, J.P., Thompson, S.G., Quantifying heterogeneity in a meta-analysis. Stat. Med. 21 (2002), 1539–1558.
39. [39] Viechtbauer, W., Conducting meta-analyses in R with the metafor package. J. Statist. Softw. 36 (2010), 1–48.
40. [40] R Project version 3.2.2, R version 3.2.2 http://www.r-project.org/, Comprehensive R Archive Network (CRAN) 2015.
41. [41] Lumley, T., Package rmeta Version 2.16. 2015, Comprehensive R Archive Network (CRAN), Seattle, Washington USA.
42. [42] Stovall, M., Weathers, R., Kasper, C., Smith, S.A., Travis, L., Ron, E., Kleinerman, R., Dose reconstruction for therapeutic and diagnostic radiation exposures: use in epidemiological studies. Radiat. Res. 166 (2006), 141–157.
43. [43] Tukenova, M., Guibout, C., Oberlin, O., Doyon, F., Mousannif, A., Haddy, N., Guérin, S., Pacquement, H., Aouba, A., Hawkins, M., Winter, D., Bourhis, J., Lefkopoulos, D., Diallo, I., de Vathaire, F., Role of cancer treatment in long-term overall and cardiovascular mortality after childhood cancer. J. Clin. Oncol. 28 (2010), 1308–1315.
44. [44] Shamsaldin, A., Grimaud, E., Hardiman, C., Diallo, I., de Vathaire, F., Chavaudra, J., Dose distribution throughout the body from radiotherapy for Hodgkin's disease in childhood. Radiother. Oncol. 49 (1998), 85–90.
45. [45] Diallo, I., Lamon, A., Shamsaldin, A., Grimaud, E., de Vathaire, F., Chavaudra, J., Estimation of the radiation dose delivered to any point outside the target volume per patient treated with external beam radiotherapy. Radiother. Oncol. 38 (1996), 269–271.
46. [46] Darby, S.C., Ewertz, M., McGale, P., Bennet, A.M., Blom-Goldman, U., Bronnum, D., Correa, C., Cutter, D., Gagliardi, G., Gigante, B., Jensen, M.B., Nisbet, A., Peto, R., Rahimi, K., Taylor, C., Hall, P., Risk of ischemic heart disease in women after radiotherapy for breast cancer. N. Engl. J. Med. 368 (2013), 987–998.
47. [47] van Nimwegen, F.A., Schaapveld, M., Cutter, D.J., Janus, C.P., Krol, A.D., Hauptmann, M., Kooijman, K., Roesink, J., van der Maazen, R., Darby, S.C., Aleman, B.M., van Leeuwen, F.E., Radiation dose-response relationship for risk of coronary heart disease in survivors of Hodgkin lymphoma. J. Clin. Oncol. 34 (2016), 235–243.
48. [48] Little, M.P., Zablotska, L.B., Lipshultz, S.E., Ischemic heart disease after breast cancer radiotherapy. N. Engl. J. Med. 368 (2013), 2523–2524.
49. [49] Darby, S.C., Doll, R., Gill, S.K., Smith, P.G., Long term mortality after a single treatment course with X-rays in patients treated for ankylosing spondylitis. Br. J. Cancer 55 (1987), 179–190.
50. [50] Zablotska, L.B., Little, M.P., Cornett, R.J., Potential increased risk of ischemic heart disease mortality with significant dose fractionation in the Canadian fluoroscopy cohort study. Am. J. Epidemiol. 179 (2014), 120–131.
51. [51] Little, M.P., Zablotska, L.B., Brenner, A.V., Lipshultz, S.E., Circulatory disease mortality in the Massachusetts tuberculosis fluoroscopy cohort study. Eur. J. Epidemiol. 31 (2016), 287–309.
52. [52] Travis, L.B., Land, C.E., Andersson, M., Nyberg, U., Goldman, M.B., Knudson, G.L., Berger, E., Storm, H.H., Hall, P., Auvinen, A., Janower, M.L., Holm, L.E., Monson, R.R., Schottenfeld, D., Boice, J.D. Jr., Mortality after cerebral angiography with or without radioactive Thorotrast: an international cohort of 3,143 two-year survivors. Radiat. Res. 156 (2001), 136–150.
53. [53] dos Santos Silva, I., Malveiro, F., Jones, M.E., Swerdlow, A.J., Mortality after radiological investigation with radioactive Thorotrast: a follow-up study of up to fifty years in Portugal. Radiat. Res. 159 (2003), 521–534.
54. [54] Tatsukawa, Y., Nakashima, E., Yamada, M., Funamoto, S., Hida, A., Akahoshi, M., Sakata, R., Ross, N.P., Kasagi, F., Fujiwara, S., Shore, R.E., Cardiovascular disease risk among atomic bomb survivors exposed in utero, 1978–2003. Radiat. Res. 170 (2008), 269–274.
55. [55] Stewart, A.M., Kneale, G.W., A-bomb survivors: factors that may lead to a re-assessment of the radiation hazard. Int. J. Epidemiol. 29 (2000), 708–714.
56. [56] Little, M.P., Absence of evidence for differences in the dose-response for cancer and non-cancer endpoints by acute injury status in the Japanese atomic-bomb survivors. Int. J. Radiat. Biol. 78 (2002), 1001–1010.
57. [57] Ozasa, K., Takahashi, I., Grant, E.J., Radiation-related risks of non-cancer outcomes in the atomic bomb survivors. Ann. ICRP 45:1 Suppl (2016), 253–261.
58. [58] Ueshima, H., Explanation for the Japanese paradox: prevention of increase in coronary heart disease and reduction in stroke. J. Atheroscler. Thromb. 14 (2007), 278–286.
59. [59] Vrijheid, M., Cardis, E., Ashmore, P., Auvinen, A., Bae, J.M., Engels, H., Gilbert, E., Gulis, G., Habib, R., Howe, G., Kurtinaitis, J., Malker, H., Muirhead, C., Richardson, D., Rodriguez-Artalejo, F., Rogel, A., Schubauer-Berigan, M., Tardy, H., Telle-Lamberton, M., Usel, M., Veress, K., Mortality from diseases other than cancer following low doses of ionizing radiation: results from the 15-Country Study of nuclear industry workers. Int. J. Epidemiol. 36 (2007), 1126–1135.
60. [60] Ivanov, V.K., Maksioutov, M.A., Chekin, S.Y., Petrov, A.V., Biryukov, A.P., Kruglova, Z.G., Matyash, V.A., Tsyb, A.F., Manton, K.G., Kravchenko, J.S., The risk of radiation-induced cerebrovascular disease in Chernobyl emergency workers. Health Phys. 90 (2006), 199–207.
61. [61] Kashcheev, V.V., Chekin, S.Y., Maksioutov, M.A., Tumanov, K.A., Menyaylo, A.N., Kochergina, E.V., Kashcheeva, P.V., Gorsky, A.I., Shchukina, N.V., Karpenko, S.V., Ivanov, V.K., Radiation-epidemiological study of cerebrovascular diseases in the cohort of Russian recovery operation workers of the Chernobyl accident. Health Phys. 111 (2016), 192–197.
62. [62] Ivanov, V.K., Gorski, A.I., Maksioutov, M.A., Tsyb, A.F., Souchkevitch, G.N., Mortality among the Chernobyl emergency workers: estimation of radiation risks (preliminary analysis). Health Phys. 81 (2001), 514–521.
63. [63] Doll, R., Fisher, R.E., Gammon, E.J., Gunn, W., Hughes, G.O., Tyrer, F.H., Wilson, W., Mortality of gasworkers with special reference to cancers of the lung and bladder, chronic bronchitis, and pneumoconiosis. Br. J. Ind. Med. 22 (1965), 1–12.
64. [64] Bell, C.M., Coleman, D.A., Models of the healthy worker effect in industrial cohorts. Stat. Med. 6 (1987), 901–909.
65. [65] Simonetto, C., Azizova, T.V., Grigoryeva, E.S., Kaiser, J.C., Schöllnberger, H., Eidemüller, M., Ischemic heart disease in workers at Mayak PA: latency of incidence risk after radiation exposure. PLoS One, 9(5), 2014, e96309.
66. [66] Simonetto, C., Schöllnberger, H., Azizova, T.V., Grigoryeva, E.S., Pikulina, M.V., Eidemüller, M., Cerebrovascular diseases in workers at Mayak PA: the difference in radiation risk between incidence and mortality. PLoS One, 10(5), 2015, e0125904.
67. [67] Azizova, T.V., Grigorieva, E.S., Hunter, N., Pikulina, M.V., Moseeva, M.B., Risk of mortality from circulatory diseases in Mayak workers cohort following occupational radiation exposure. J. Radiol. Prot. 35 (2015), 517–538.
68. [68] Azizova, T.V., Haylock, R.G.E., Moseeva, M.B., Bannikova, M.V., Grigoryeva, E.S., Cerebrovascular diseases incidence and mortality in an extended Mayak worker cohort 1948–1982. Radiat. Res. 182 (2014), 529–544.
69. [69] Azizova, T.V., Bannikova, M.V., Grigorieva, E.S., Bagaeva, Y.P., Azizova, E.V., Risk of lower extremity arterial disease in a cohort of workers occupationally exposed to ionizing radiation over a prolonged period. Radiat. Environ. Biophys. 55 (2016), 147–159.
70. [70] Azizova, T.V., Muirhead, C.R., Druzhinina, M.B., Grigoryeva, E.S., Vlasenko, E.V., Sumina, M.V., O'Hagan, J.A., Zhang, W., Haylock, R.G.E., Hunter, N., Cardiovascular diseases in the cohort of workers first employed at Mayak PA in 1948–1958. Radiat. Res. 174 (2010), 155–168.
71. [71] Azizova, T.V., Muirhead, C.R., Druzhinina, M.B., Grigoryeva, E.S., Vlasenko, E.V., Sumina, M.V., O'Hagan, J.A., Zhang, W., Haylock, R.G.E., Hunter, N., Cerebrovascular diseases in the cohort of workers first employed at Mayak PA in 1948–1958. Radiat. Res. 174 (2010), 851–864.
72. [72] Wakeford, R., Tawn, E.J., The meaning of low dose and low dose-rate. J. Radiol. Prot. 30 (2010), 1–3.
73. [73] Muirhead, C.R., O'Hagan, J.A., Haylock, R.G.E., Phillipson, M.A., Willcock, T., Berridge, G.L.C., Zhang, W., Mortality and cancer incidence following occupational radiation exposure: third analysis of the National Registry for Radiation Workers. Br. J. Cancer 100 (2009), 206–212.
74. [74] Kreuzer, M., Kreisheimer, M., Kandel, M., Schnelzer, M., Tschense, A., Grosche, B., Mortality from cardiovascular diseases in the German uranium miners cohort study, 1946–1998. Radiat. Environ. Biophys. 45 (2006), 159–166.
75. [75] Kreuzer, M., Dufey, F., Sogl, M., Schnelzer, M., Walsh, L., External gamma radiation and mortality from cardiovascular diseases in the German WISMUT uranium miners cohort study, 1946–2008. Radiat. Environ. Biophys. 52 (2013), 37–46.
76. [76] Lane, R.S.D., Frost, S.E., Howe, G.R., Zablotska, L.B., Mortality (1950–1999) and cancer incidence (1969–1999) in the cohort of Eldorado uranium workers. Radiat. Res. 174 (2010), 773–785.
77. [77] Laurent, O., Metz-Flamant, C., Rogel, A., Hubert, D., Riedel, A., Garcier, Y., Laurier, D., Relationship between occupational exposure to ionizing radiation and mortality at the French electricity company, period 1961–2003. Int. Arch. Occup. Environ. Health 83 (2010), 935–944.
78. [78] McGeoghegan, D., Binks, K., Gillies, M., Jones, S., Whaley, S., The non-cancer mortality experience of male workers at British Nuclear Fuels plc, 1946–2005. Int. J. Epidemiol. 37 (2008), 506–518.
79. [79] Krestinina, L.Y., Epifanova, S., Silkin, S., Mikryukova, L., Degteva, M., Shagina, N., Akleyev, A., Chronic low-dose exposure in the Techa River Cohort: risk of mortality from circulatory diseases. Radiat. Environ. Biophys. 52 (2013), 47–57.
80. [80] Grosche, B., Lackland, D.T., Land, C.E., Simon, S.L., Apsalikov, K.N., Pivina, L.M., Bauer, S., Gusev, B.I., Mortality from cardiovascular diseases in the Semipalatinsk historical cohort, 1960–1999, and its relationship to radiation exposure. Radiat. Res. 176 (2011), 660–669.
81. [81] Danilova, I., Shkolnikov, V.M., Jdanov, D.A., Mesle, F., Vallin, J., Identifying potential differences in cause-of-death coding practices across Russian regions. Popul. Health Metr., 14, 2016, 8.
82. [82] Wasserman, D., Varnik, A., Reliability of statistics on violent death and suicide in the former USSR, 1970–1990. Acta Psychiatr. Scand. Scand 98:Suppl. 394 (1998), 34–41.
83. [83] Schultz-Hector, S., Trott, K.R., Radiation-induced cardiovascular diseases: is the epidemiologic evidence compatible with the radiobiologic data?. Int. J. Radiat. Oncol. Biol. Phys. 67 (2007), 10–18.
84. [84] United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR), UNSCEAR 2006 Report. Annex B. Epidemiological Evaluation of Cardiovascular Disease and Other Non-Cancer Diseases Following Radiation Exposure., 2008, United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR), United Nations New York, 325–383.
85. −/− mice. Radiat. Res. 175 (2011), 665–676.
86. [86] Kusunoki, Y., Kyoizumi, S., Hirai, Y., Suzuki, T., Nakashima, E., Kodama, K., Seyama, T., Flow cytometry measurements of subsets of T, B and NK cells in peripheral blood lymphocytes of atomic bomb survivors. Radiat. Res. 150 (1998), 227–236.
87. [87] Danesh, J., Whincup, P., Lewington, S., Walker, M., Lennon, L., Thomson, A., Wong, Y.K., Zhou, X., Ward, M., Chlamydia pneumoniae IgA titres and coronary heart disease. Prospective study and meta-analysis. Eur. Heart J. 23 (2002), 371–375.
88. [88] Ridker, P.M., Inflammation, infection, and cardiovascular risk: how good is the clinical evidence?. Circulation 97 (1998), 1671–1674.
89. [89] Whincup, P., Danesh, J., Walker, M., Lennon, L., Thomson, A., Appleby, P., Hawkey, C., Atherton, J., Prospective study of potentially virulent strains of Helicobacter pylori and coronary heart disease in middle-aged men. Circulation 101 (2000), 1647–1652.
90. [90] Cannon, C.P., Braunwald, E., McCabe, C.H., Grayston, J.T., Muhlestein, B., Giugliano, R.P., Cairns, R., Skene, A.M., Pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction investigators, Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome. N. Engl. J. Med. 352 (2005), 1646–1654.
91. [91] Grayston, J.T., Kronmal, R.A., Jackson, L.A., Parisi, A.F., Muhlestein, J.B., Cohen, J.D., Rogers, W.J., Crouse, J.R., Borrowdale, S.L., Schron, E., Knirsch, C., ACES Investigators, Azithromycin for the secondary prevention of coronary events. N. Engl. J. Med. 352 (2005), 1637–1645.
92. [92] Little, M.P., Gola, A., Tzoulaki, I., A model of cardiovascular disease giving a plausible mechanism for the effect of fractionated low-dose ionizing radiation exposure. PLoS Comput. Biol., 5, 2009, e1000539.
93. [93] Lowe, D., Raj, K., Premature aging induced by radiation exhibits pro-atherosclerotic effects mediated by epigenetic activation of CD44 expression. Aging Cell 13 (2014), 900–910.
94. [94] Rombouts, C., Aerts, A., Quintens, R., Baselet, B., El-Saghire, H., Harms-Ringdahl, M., Haghdoost, S., Janssen, A., Michaux, A., Yentrapalli, R., Benotmane, M.A., Van Oostveldt, P., Baatout, S., Transcriptomic profiling suggests a role for IGFBP5 in premature senescence of endothelial cells after chronic low dose rate irradiation. Int. J. Radiat. Biol. 90 (2014), 560–574.
95. [95] Creager, M.A., Lüscher, T.F., Cosentino, F., Beckman, J.A., Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Circulation 108 (2003), 1527–1532.
96. [96] Adams, M.J., Grant, E.J., Kodama, K., Shimizu, Y., Kasagi, F., Suyama, A., Sakata, R., Akahoshi, M., Radiation dose associated with renal failure mortality: a potential pathway to partially explain increased cardiovascular disease mortality observed after whole-body irradiation. Radiat. Res. 177 (2012), 220–228.
97. [97] Lenarczyk, M., Lam, V., Jensen, E., Fish, B.L., Su, J., Koprowski, S., Komorowski, R.A., Harmann, L., Migrino, R.Q., Li, X.A., Hopewell, J.W., Moulder, J.E., Baker, J.E., Cardiac injury after 10 Gy total body irradiation: indirect role of effects on abdominal organs. Radiat. Res. 180 (2013), 247–258.
98. [98] Kleinerman, R.A., Weinstock, R.M., Mabuchi, K., High-dose abdominal radiotherapy and risk of diabetes mellitus. Arch. Intern. Med. 170 (2010), 1506–1507.
99. [99] de Vathaire, F., El-Fayech, C., Ben Ayed, F.F., Haddy, N., Guibout, C., Winter, D., Thomas-Teinturier, C., Veres, C., Jackson, A., Pacquement, H., Schlumberger, M., Hawkins, M., Diallo, I., Oberlin, O., Radiation dose to the pancreas and risk of diabetes mellitus in childhood cancer survivors: a retrospective cohort study. Lancet Oncol. 13 (2012), 1002–1010.
100. [100] van Nimwegen, F.A., Schaapveld, M., Janus, C.P.M., Krol, A.D.G., Raemaekers, J.M.M., Kremer, L.C.M., Stovall, M., Aleman, B.M.P., van Leeuwen, F.E., Risk of diabetes mellitus in long-term survivors of Hodgkin lymphoma. J. Clin. Oncol. 32 (2014), 3257–3263.
101. [101] Belsky, J.L., Tachikawa, K., Jablon, S., The health of atomic bomb survivors: a decade of examinations in a fixed population. Yale J. Biol. Med. 46 (1973), 284–296.
102. [102] Fujiwara, S., Sposto, R., Shiraki, M., Yokoyama, N., Sasaki, H., Kodama, K., Shimaoka, K., Levels of parathyroid hormone and calcitonin in serum among atomic bomb survivors. Radiat.Res 137 (1994), 96–103.
103. [103] Andersson, P., Rydberg, E., Willenheimer, R., Primary hyperparathyroidism and heart disease–a review. Eur. Heart J. 25 (2004), 1776–1787.
104. [104] Townsend, N., Bhatnagar, P., Wilkins, E., Wickramasinghe, K., Rayner, M., Cardiovascular disease statistics. 2015, British Heart Foundation, London, UK.
105. [105] Office for National Statistics (ONS), Mortality Statistics Cause. Series DH2 No. 30. Review of the Registrar General on Deaths by Cause, Sex and Age, in England and Wales, 2003. 2004, Her Majesty's Stationery Office, 1–291.
106. [106] Richardson, D.B., Wing, S., Radiation and mortality of workers at Oak Ridge National Laboratory: positive associations for doses received at older ages. Environ. Health Perspect. 107 (1999), 649–656.
107. [107] Prentice, R.L., Pyke, R., Logistic disease incidence models and case-control studies. Biometrika 66 (1979), 403–411.
108. [108] McCullagh, P., Nelder, J.A., Generalized linear models. Monographs on Statistics and Applied Probability 37, 2nd edition, 1989, Chapman and Hall/CRC, Boca Raton, FL, 1–526.
109. [109] Risk Sciences International, Epicure Version 2.0.1.0., Risk Sciences International, 55 Metcalfe, K1P 6L5. 2015, Risk Sciences International, Canada.
110. [110] N.E. Breslow, N.E. Day, Statistical methods in cancer research. Volume 1 – The analysis of case-control studies, IARC Sci. Publ. 32 (1980) 1–350.